Qingdao Vland Biotech INC. (SHA:603739)
China · Delayed Price · Currency is CNY 12.91
-0.24 (-1.83%)
Jun 2, 2026, 3:00 PM CST
SHA:603739 Market Cap
SHA:603739 has a market cap or net worth of 3.27 billion as of June 2, 2026. Its market cap has increased by 0.08% in one year.
Market Cap
3.27B
Enterprise Value
3.59B
Revenue
1.40B
Ranking
n/a
PE Ratio
41.87
Stock Price
12.91
Market Cap Chart
Since January 16, 2019, SHA:603739's market cap has increased from 2.27B to 3.27B, an increase of 43.97%. That is a compound annual growth rate of 5.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 3.27B | -8.76% |
| Dec 31, 2025 | 3.58B | 18.02% |
| Dec 31, 2024 | 3.03B | -21.22% |
| Dec 29, 2023 | 3.85B | 13.69% |
| Dec 30, 2022 | 3.39B | -27.76% |
| Dec 31, 2021 | 4.69B | 34.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hefei Lifeon Pharmaceutical | 3.77B |
| Pulike Biological Engineering | 3.63B |
| Jiangsu Sihuan Bioengineering | 3.60B |
| Baolingbao Biology | 3.50B |
| Shanghai Shen Lian Biomedical | 3.29B |
| Hubei Goto Biopharm | 3.16B |
| Landfar Bio-medicine | 3.15B |
| Guanhao Biotech | 3.14B |